C
Claudio Pasquali
Researcher at University of Padua
Publications - 174
Citations - 6158
Claudio Pasquali is an academic researcher from University of Padua. The author has contributed to research in topics: Pancreas & Pancreatic cancer. The author has an hindex of 37, co-authored 160 publications receiving 5657 citations.
Papers
More filters
Journal ArticleDOI
Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.
Sergio Pedrazzoli,Valerio DiCarlo,Renzo Dionigi,Franco Mosca,Paolo Pederzoli,Claudio Pasquali,Günter Klöppel,Karl Dhaene,Fabrizio Michelassi +8 more
TL;DR: The addition of an extended lymphadenectomy and retroperitoneal soft-tissue clearance to a pancreatoduodenal resection does not significantly increase morbidity and mortality rates, and overall survival does not differ between the two groups.
Journal ArticleDOI
Survival after resection for ductal adenocarcinoma of the pancreas
TL;DR: It is suggested that patient characteristics and tumour findings rather than operative procedures affect long‐term survival after resection for pancreatic carcinoma.
Journal ArticleDOI
Recurrence after resection for ductal adenocarcinoma of the pancreas
TL;DR: It appears that surgery alone is an inadequate treatment for cure in patients with pancreatic carcinoma, and effective adjuvant therapies are needed to improve locoregional control of pancreatic cancer after surgical resection.
Journal ArticleDOI
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome.
Paola Fogar,Cosimo Sperti,Daniela Basso,M. Sanzari,Eliana Greco,Carla Davoli,Filippo Navaglia,Carlo-Federico Zambon,Claudio Pasquali,Enzo Venza,Sergio Pedrazzoli,Mario Plebani +11 more
TL;DR: The survival of patients with pancreatic cancer depends mainly on tumor stage, but it is also affected by the number of circulating lymphocytes, suggesting that the immune system plays an important role in pancreatic adenocarcinoma immunosurveillance and immunoediting.
Journal ArticleDOI
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer
Erica J. Childs,Evelina Mocci,Daniele Campa,Daniele Campa,Paige M. Bracci,Steven Gallinger,Michael Goggins,Donghui Li,Rachel E. Neale,Sara H. Olson,Ghislaine Scelo,Laufey T. Amundadottir,William R. Bamlet,Maarten F. Bijlsma,Amanda L. Blackford,Michael Borges,Paul Brennan,Hermann Brenner,H. Bas Bueno-de-Mesquita,Federico Canzian,Gabriele Capurso,Giulia Martina Cavestro,Kari G. Chaffee,Stephen J. Chanock,Sean P. Cleary,Michelle Cotterchio,Lenka Foretova,Charles S. Fuchs,Niccola Funel,Maria Gazouli,Manal M. Hassan,Joseph M. Herman,Ivana Holcatova,Elizabeth A. Holly,Robert N. Hoover,Rayjean J. Hung,Vladimir Janout,Timothy J. Key,Juozas Kupcinskas,Robert C. Kurtz,Stefano Landi,Lingeng Lu,Ewa Małecka-Panas,Andrea Mambrini,Beatrice Mohelnikova-Duchonova,John P. Neoptolemos,Ann L. Oberg,Irene Orlow,Claudio Pasquali,Raffaele Pezzilli,Cosmeri Rizzato,Amethyst Saldia,Aldo Scarpa,Rachael Z. Stolzenberg-Solomon,Oliver Strobel,Francesca Tavano,Yogesh K. Vashist,Pavel Vodicka,Brian M. Wolpin,Herbert Yu,Gloria M. Petersen,Harvey A. Risch,Alison P. Klein +62 more
TL;DR: This study identifies new loci associated with pancreatic cancer risk in North America, Central Europe and Australia and replicated previously reported associations at 9q34.2 (ABO), 13q22.1 (KLF5), 5p15.33 (TERT and CLPTM1) and 13q12.4 (NR5A2), a region with previous suggestive evidence in Han Chinese.